2021-04-15

Mar 17, 2021 • 8:30 AM EDT. BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021

12 Jan 2021 Biolase (NASDAQ:BIOL) stock is flying high on Tuesday after announcing a massive and are protected by about 271 patents and 40 patent-pending technologies. Best Cryptocurrency Stocks To Buy Before April 2021? Benzinga - Sat, 20 Mar 2021 09:52:31 -0400. Biolase Shares Tick Slightly Higher On Volume As Traders Circulate European Patent Office Specification for Co. 16 Mar 2021 FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire via and 40 patent- pending technologies designed to provide biologically and 16 Mar 2021 BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide 14 Mar 2021 With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers 16 Mar 2021 FOOTHILL RANCH, Calif.

Our Nordic Clinic Priser SciVision Medical / BIOLASE Nordic, Regus Business Center fotografia. Justia - Patents - Patents and Patent Application Resources Patents Assigned to BIOLASE, Inc. Publication date: March 18, 2021 Applicant: Biolase, Inc. BIOLASE, Inc. (BIOL) was awarded a new patent titled "Non-Contact Handpiece for Laser Tissue Cutting" by the U.S. Patent and Trademark Office. IRVINE, Calif., March 3, 2021 /PRNewswire via COMTEX/ -- IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE 271 patented and 40 patent-pending technologies designed to provide biologically BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain Application Filed: 2021-03-18 Trademark Application Details Mark For: RAPID™ trademark registration is intended to cover the categories of electromagnetic energy emitting devices for use in dentistry, and parts and components therefor; Dental instruments for use in root canal cleaning, shaping, and disinfection in dental endodontics. Mar 17, 2021 • 8:30 AM EDT. BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021 BIOLASE has secured a new patent for use of its laser technology in ophthalmic applications. Biolase laser products are proprietary and are protected by about 271 patents and 40 patent-pending technologies.

The Adjourned BIOLASE Special Meeting Reconvenes Tuesday, February 16, 2021.

Biolase has 190 employees across 4 locations and $37.80 M in annual revenue in FY 2019. See insights on Biolase including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Quick access to patent information databases and other helpful resources. 19 Jan 2021 What's been a driving force for Biolase?

3 Mar 2011 CHICAGO: Biolase Technology, a dental laser manufacturer and distributor, announced The company's laser products incorporate patented and patent pending Get to the 'Heart of Dentistry' at 2021 Midwinter

A great opportunity to learn from Plastic Aesthetic and Reconstructive Surgeon, Dr Mario Trelles who has extensive, lifetime experience working with almost every kind of laser in aesthetic surgery. Biolase, Lake Forest, California.

BIOLASE is the world’s leading innovator in dental lasers. With thousands of lasers in use in operatories worldwide, millions of patients have experienced the benefits of laser dentistry, such as less aerosols, gentler procedures and comfortable healing.
Ferienhaus smaland kalmar

With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers allow it to claim some of the most advanced dental laser system options on the market. BIOL. The Adjourned BIOLASE Special Meeting Reconvenes Tuesday, February 16, 2021.

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Biolase, Inc. Biolase Inc USPTO Trademark & Patent Filings. Trademark applications and grants for Biolase Inc. Biolase Inc has 41 trademark applications.
Kapitalverluste verrechnen

asperger light syndrome
vilken högsta hastighet gäller för tung lastbil på en 100 väg
ica lagret sommarjobb
inläsningscentralen försäkringskassan östersund
sverige grupp immunitet

BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance Mar 17, 2021 • 8:30 AM EDT BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021

FOOTHILL RANCH, Calif., Feb. 1, 2021/PRNewswire/ -- BIOLASE, Inc.(NASDAQ: BIOL), the global leader in dental 2021-02-21 · Then, late last week, the company gained attention following patent news. In particular, this wasn’t found on the company’s headlines but from European Patent Office’s website. Biolase, Inc. received an Intention to Grant a European Patent for Application No. 13155470.1, titled: MODIFIED-OUTPUT FIBER OPTIC TIPS.

Virtualisering windows 10
atlant havs vägen

Biolase has 190 employees across 4 locations and $37.80 M in annual revenue in FY 2019. See insights on Biolase including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

3 Mar 2011 CHICAGO: Biolase Technology, a dental laser manufacturer and distributor, announced The company's laser products incorporate patented and patent pending Get to the 'Heart of Dentistry' at 2021 Midwinter

BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance Mar 17, 2021 • 8:30 AM EDT BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021

20 Jul 2011 The U.S. Patent and Trademark Office has issued Biolase Technology two new patents covering the use of its laser technologies for treating